AIE-active lysosome-targeted fluorescent organic nanoparticles for leucine aminopeptidase-activatable fluorescent imaging and precision photodynamic therapy potential
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
2. Engineering of BODIPY-based theranostics for cancer therapy10.1016/j.ccr.2022.214908 ↗
3. Design and synthesis of symmetrical pentamethine cyanine dyes as NIR photosensitizers for PDT10.1016/j.dyepig.2018.09.009 ↗
4. Emerging nanotherapeutics for facilitating photodynamic therapy
5. Activatable photosensitizers: agents for selective photodynamic therapy10.1039/C6CS00616G ↗
6. Activatable photosensitizers: agents for selective photodynamic therapy
7. Recent advances in supramolecular activatable phthalocyanine-based photosensitizers for anti-cancer therapy10.1016/j.ccr.2021.214155 ↗
8. A leucine aminopeptidase activatable photosensitizer for cancer cellselective photodynamic therapy action10.1016/j.dyepig.2021.109735 ↗
9. Specific light-up bioprobe with aggregation-induced emission and activatable photoactivity for the targeted and image-guided photodynamic ablation of cancer cells10.1002/anie.201408476 ↗
10. Lipid droplet-targetable fluorescence guided photodynamic therapy of cancer cells with an activatable AIE-active fluorescent probe for hydrogen peroxide10.1002/adom.202001119 ↗
11. Most recent advances on enzyme-activatable optical probe for bioimaging10.1002/agt2.32 ↗
12. Three birds one stone: an enzyme-activatable theragnostic agent for fluorescence diagnosis, photodynamic and inhibitor therapies10.1039/D3CC00214D ↗
13. Organelle-targeted photosensitizers for precision photodynamic therapy10.1021/acsami.1c02019 ↗
14. Organelle-targeted photothermal agents for cancer therapy10.1039/D1CC02168K ↗
15. GSH and H2O2 Co-activatable mitochondria-targeted photodynamic therapy under normoxia and hypoxia10.1002/anie.202003895 ↗
16. Activatable dual ROS-producing probe for dual organelle-engaged photodynamic therapy10.1021/acsabm.1c00354 ↗
17. The lysosome as an imperative regulator of autophagy and cell death10.1007/s00018-021-03988-3 ↗
18. Aggregated carbon dots-loaded macrophages treat sepsis by eliminating multidrug-resistant bacteria and attenuatin inflammation10.1002/agt2.200 ↗
19. Lysosomes and autophagy in cell death control10.1038/nrc1738 ↗
20. Lysosomes as a therapeutic target10.1038/s41573-019-0036-1 ↗
21. NIR-excited superoxide radical procreators to eradicate tumors by targeting the lyso-membrane10.1039/C9TB00721K ↗
22. A self-assembled nanophotosensitizer targets lysosomes and induces lysosomal membrane permeabilization to enhance photodynamic therapy10.1039/D3SC00455D ↗
23. Diplatinum(II) catecholate of photoactive boron-dipyrromethene for lysosome-targeted photodynamic therapy in red light10.1021/acs.inorgchem.9b00567 ↗
24. Autophagy-activated self-reporting photosensitizer promoting cell mortality in cancer starvation therapy
25. A facile composite nanoparticle promoted by photoelectron transfer and consumption for tumor combination therapy10.1039/D0QM00447B ↗
26. Leucine aminopeptidases: diversity in structure and function10.1515/BC.2006.191 ↗
27. Fluorescent probes for detection and bioimaging of leucine aminopeptidase
28. Recent progresses in small-molecule enzymatic fluorescent probes for cancer imaging10.1039/C7CS00862G ↗
29. A ratiometric fluorescent probe for monitoring leucine aminopeptidase in living cells and zebrafish model10.1021/acs.analchem.7b02910 ↗
30. In vivo imaging of leucine aminopeptidase activity in drug-induced liver injury and liver cancer via a near-infrared fluorescent probe10.1039/C6SC05712H ↗
31. Aggregation-induced emission: recent advances in materials and biomedical applications10.1002/anie.202000845 ↗
32. Aggregation-induced emission10.1039/c1cs15113d ↗
33. Precise design and synthesis of an AIE-active glutathione fluorescent probe and its exogenous biological imaging10.1016/j.dyepig.2023.111481 ↗
34. Ion−π interactions for constructing organic luminescent materials10.1002/agt2.285 ↗
35. Trojan horse-like nano-AIE aggregates based on homologous targeting strategy and their photodynamic therapy in anticancer application10.1002/advs.202102561 ↗
36. A boronic acid-functionalized phthalocyanine with an aggregation-enhanced photodynamic effect for combating antibiotic-resistant bacteria10.1039/D0SC01351J ↗
37. BODIPY as a multifunctional theranostic reagent in biomedicine: self-assembly, properties, and applications10.1002/adma.202207546 ↗
38. BODIPY-based probes for the fluorescence imaging of biomolecules in living cells10.1039/C5CS00030K ↗
39. BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen10.1002/anie.202106748 ↗
40. New BODIPYs for photodynamic therapy (PDT): synthesis and activity on human cancer cell lines10.1016/j.bmc.2020.115737 ↗
41. A general strategy toward highly fluorogenic bioprobes emitting across the visible spectrum10.1021/jacs.7b05920 ↗
42. Specific activation of photosensitizer with extrinsic enzyme for precisive photodynamic therapy10.1021/jacs.2c04017 ↗
43. Design and synthesis of a NAD(P)H:quinone oxidoreductase 1-activatable photosensitiser for controlled photodynamic therapy10.1039/D3CC00683B ↗
44. Intraorgan targeting of gold conjugates for precise liver cancer treatment10.1021/acsami.7b08969 ↗
45. Lysosome-targeting chimeras evolve10.1038/s41589-021-00835-1 ↗
46. Water-soluble meso-ester substituted BODIPY with aggregation-induced emission property for ratiometric detection of carboxylesterases in living hepatoma cell10.1016/j.dyepig.2022.110189 ↗
47. Effect of AIE substituents on the fluorescence of tetraphenylethene-containing BODIPY derivatives10.1021/acsami.5b05033 ↗
48. Towards meso-ester BODIPYs with aggregation-induced emission properties: the effect of substitution positions10.1002/asia.201500420 ↗
49. Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC)
50. Enzyme-activated near-infrared fluorogenic probe with high-efficiency intrahepatic targeting ability for visualization of drug-induced liver injury10.1039/D1SC04825B ↗
51. Leucine aminopeptidase may contribute to the intrinsic resistance of cancer cells toward cisplatin as revealed by an ultrasensitive fluorescent probe10.1039/C5SC03600C ↗
52. Targeting lysosomal degradation pathways: new strategies and techniques for drug discovery10.1021/acs.jmedchem.0c01689 ↗
53. Lysosome-targeting strategy using polypeptides and chimeric molecules10.1021/acsomega.1c04771 ↗
54. Development of triantennary N-acetylgalactosamine conjugates as degraders for extracellular proteins10.1021/acscentsci.1c00146 ↗
55. Targeted multimodal theranostics via biorecognition controlled aggregation of metallic nanoparticle composites10.1039/C6SC01463A ↗
56. Defect engineering of layered double hydroxide nanosheets as inorganic photosensitizers for NIR-III photodynamic cancer therapy10.1038/s41467-022-31106-9 ↗